Board Meetings for ALKEM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ALKEM | Alkem Laboratories Limited | 28 May 2026 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. | |
| ALKEM | Alkem Laboratories Limited | 28 May 2026 | Financial Results/Dividend | Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 28th May, 2026, inter alia:(i) To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2026; and (ii) To consider and recommend Final Dividend, if any, for financial year ended 31st March, 2026. | |
| ALKEM | Alkem Laboratories Limited | 13 Feb 2026 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Dividend. | |
| ALKEM | Alkem Laboratories Limited | 13 Feb 2026 | Financial Results/Dividend | Notice of meeting of the Board of Directors of Alkem Laboratories Limited ( the Company ) | |
| ALKEM | Alkem Laboratories Limited | 13 Nov 2025 | Financial Results | Notice of meeting of the Board of Directors of the Company scheduled to be held on Thursday, 13th November, 2025, inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2025. | |
| ALKEM | Alkem Laboratories Limited | 13 Nov 2025 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | |
| ALKEM | Alkem Laboratories Limited | 12 Aug 2025 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | |
| ALKEM | Alkem Laboratories Limited | 12 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 | |
| ALKEM | Alkem Laboratories Limited | 29 May 2025 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend. | |
| ALKEM | Alkem Laboratories Limited | 29 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and final dividend, if any | |
| ALKEM | Alkem Laboratories Limited | 07 Feb 2025 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend. | |
| ALKEM | Alkem Laboratories Limited | 07 Feb 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2024 and dividend | |
| ALKEM | Alkem Laboratories Limited | 13 Nov 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 | |
| ALKEM | Alkem Laboratories Limited | 13 Nov 2024 | Board Meeting Intimation | ALKEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . | |
| ALKEM | Alkem Laboratories Limited | 09 Aug 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Showing page 1 of 4 (56 total items)